Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, par value $.001 per share
-
Shares outstanding
-
10.5M
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
1.39M
-
Shares change
-
+1.2M
-
Total reported value, excl. options
-
$1.61M
-
Value change
-
+$1.37M
-
Number of buys
-
15
-
Number of sells
-
-5
-
Price
-
$1.16
Significant Holders of SOLIGENIX, INC. - Common Stock, par value $.001 per share (SNGX) as of Q3 2025
24 filings reported holding SNGX - SOLIGENIX, INC. - Common Stock, par value $.001 per share as of Q3 2025.
SOLIGENIX, INC. - Common Stock, par value $.001 per share (SNGX) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.39M shares
of 10.5M outstanding shares and own 13.19% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (708K shares), DRW Securities, LLC (171K shares), TWO SIGMA INVESTMENTS, LP (87.6K shares), SABBY MANAGEMENT, LLC (81K shares), RENAISSANCE TECHNOLOGIES LLC (72.9K shares), HRT FINANCIAL LP (54.7K shares), VANGUARD GROUP INC (52.5K shares), Virtu Financial LLC (50.9K shares), Banco BTG Pactual S.A. (46.4K shares), and GEODE CAPITAL MANAGEMENT, LLC (42.6K shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.